Archive for November, 2007

Sunday Chat With S. Jay Olshansky at the Immortality Institute

Thursday, November 29th, 2007

Researcher S. Jay Olshansky will be the guest at the next Sunday chat hosted by the Immortality Institute:

I am happy to announce SJ Olshansky will be joining Imminst for the Sunday Night Chat this Sunday December 2nd at 6:30pm CST U.S. If you are not familiar with Professor Olshanksy...you should be. He was researching methods to slow aging while most Imminst members were still in diapers. He has seen all the hype, the successes, and failures. His latest endeavor is the The Longevity Dividend, which proposes to set aside 3 billion (that's billion with a B) dollars a year of NIH funding for the study of aging.

Chat Room: http://www.imminst.org/chat

Sun December 2nd
- 4:30 Pacific
- 5:30 Mountain
- 6:30 Central
- 7:30 Eastern

You can look back in the archives here for much more on the Longevity Dividend:

As far as I can see, Olshansky is in the camp of "metabolic re-engineering and slow but solid progress in slowing aging is the way ahead, but it'd be wonderful if things that worked far better were demonstrated to be plausible." Which is hopefully a transitionary stage on the way to "I always thought that the Strategies for Engineered Negligible Senescence was a great idea." We'll see.

Biology: Always More Complicated Than First Thought

Thursday, November 29th, 2007

One of the constants of our present age of change and progress is that biology is always more complex than first thought. It's a given. Evolution is under no constraint to produce designs that fall within the bounds of complexity we feel comfortable taking in at one sitting.

The scientific community will still master our biology - reverse-engineer it, replicate it, and ultimately greatly improve on it - but we shouldn't be surprised when hoped-for simplicities in biological mechanisms fail to materialize. That's all the more reason for greater support and funding for efficient, goal-driven medical research.

MIT: Stem-cell therapies for brain more complicated than thought:

MIT scientists report that adult stem cells produced in the brain are pre-programmed to make only certain kinds of connections - making it impossible for a neural stem cell originating in the brain to be transplanted to the spinal cord, for instance, to take over functions for damaged cells.

...

"A stem cell that produces neurons that could be useful to replace neurons in the cerebral cortex (the type of neurons lost in Alzheimer's disease) will be most likely useless to replace neurons lost in the spinal cord. [Moreover], because there are many different types of neurons in the cerebral cortex, it is likely that we will have to figure out how to program stem cells to become many different types of neurons, each of them with a different set of pre-specified connections."

"In the stem cell field, it is generally thought that the main limitation to achieve brain repair is simply for the new neurons to reach a given brain region and to ensure their survival. Once there, it has been assumed that stem cells will ‘know what to do’ and will become the type of neuron that is missing. It seems that is not the case at all. Our experiments indicate that things are much more complicated."

Meanwhile, Over at the Immortality Institute …

Tuesday, November 27th, 2007

The Immortality Institute volunteers are upgrading; always a painful process with a large forum and a content management system extensively customized over the years. If you haven't stopped by the Institute forum in a while, you should do so. Where else are likely to be able to participate in a discussion on the first recorded practitioner of calorie restriction - and noted author of the Renaissance - with researcher S. Jay Olshansky and other noteworthies?

A noble idea is a noble idea, and we shouldn't be surprised to find people from the past with constructive contributions to make on the topic of healthy longevity - taking into account the state of scientific knowledge in their time:

Sixteenth century Venetian Ambassador and Renaissance Christian Luigi Cornaro was celebrated in his time for his stance on dietary self-restraint, moderate living, and living to the age of 103. For these hundred of years his classic book has survived as a renowned text on longevity and an inspiring treatise on the path of temperance that the author believed could lead anyone out of a state of illness and into a healthy long life. The Art of Living Long contains Cornaros four discourses, respectively concerned with demonstrating his ideas through his own example, exploring the necessity of temperate habits, assuring a happy old age, and exhorting mankind to follow his rule. With introductions by Dr. Gerald Gruman and Joseph Addison, and additional essays by Lord Bacon and Sir William Temple.

To take a contrary point of view, however, is this really any different - important names of centuries past aside - from the standard mainstream media coverage of centenarians today? The form requires the journalist to ask for the centernarian's thoughts on longevity, but living for a long time doesn't make you an expert on how to live for a long time. Everyone has an opinion on how it is they've lived so long, but opinion isn't science.

When you're wandering through the vast libraries of writing on the topics of aging and longevity, remember that the scientific method is how progress is made. Opinions can be good, can be well-thought, can even be right as it later turns out, but opinions alone are not the foundation for a path forward.

A Nice Turn of Phrase

Sunday, November 25th, 2007

This caught my eye while I was meandering my way through PubMed; a nice turn of phrase in this way of looking at the mechanisms of aging and the future of aging in a world shaped by human action.

Senescence Viewed through the Lens of Comparative Biology:

Although mortality and longevity are inherently biological phenomena, their study has historically been the purview of demography and the actuarial sciences. An infusion of biological thinking into these disciplines transforms demography into biodemography and provides expectations and coherency to observations on age-determined mortality that would not be explainable otherwise.

Comparative biology teaches us that reproduction is life's solution to the inevitability of death in the hostile environments of Earth. That solution, however, places a higher priority on investing physiological resources into reproduction that could otherwise have been used to maintain the soma (body) longer. As such, aging is an inescapable but inadvertent byproduct of imperfect maintenance and its attendant surveillance and repair. Biology also reveals that while bodies are not designed to fail, neither are they designed for extended operation. In other words, bodies are subject to biological warranty periods for normal operation. For sexually reproducing species, that warranty period includes the time from conception to sexual maturity, the production and nurturing of offspring, and a period of grand-parenting in some species.

Humans are the only species capable of exploiting the loophole in the biological contract of life (bodies that are not designed to fail). Human ingenuity (science, medicine, public health) has produced interventions that manufacture survival time by delaying death, and in so doing, has created a phenomenon never before seen in the history of life - population aging (and all the societal and health consequences that go with it).

Aging and individual death might well be the inevitable consequence of evolutionary pressure on cellular life, but it's far more noteworthy that we have the capacity to do something about it. Intelligence and technology are a loophole big enough to created physical immortality - given enough resources and time. The big question is whether the first stages on the road to the repair of aging and greatly increased healthy life spans happen rapidly enough to benefit you and I, or whether cryosuspension will be our only opportunity.

The choice is ours; how much do we want healthy longevity and how much are we prepared to work towards that goal?

AC5 Longevity Mutants

Friday, November 23rd, 2007

Mice lacking the gene to create the protein adenylyl cyclase 5 (AC5) live longer. This was accidentally discovered during research into potential heart therapies, and published earlier this year:

The new discovery, that knocking out a single cardiac gene could lengthen lifespan, was an unexpected byproduct of heart research. ... mutant mice lacking [the gene for protein] AC5 were more resistant to heart failure caused by pressure within the heart. But in the process, the research team also realised that the mutant mice lived longer than their normal counterparts. [Now] they report that the treated mice lived 30% longer and did not develop the heart stress and bone deterioration that often accompanies ageing.

Like many longevity mutations of this magnitude, this is thought to invoke the beneficial mechanisms of calorie restriction in some way. Researchers are still working on clarifying the action of the AC5 mutation, as illustrated by the latest paper on the topic:

Adenylyl Cyclase 5: A New Clue in the Search for the "Fountain of Youth"?

It is proposed that these beneficial effects may be the result of the increased activity of second messenger signaling proteins such as mitogen-activated or extracellular signal-regulated protein kinase kinase (MAPKK, also known as MEK) and extracellular signal-regulated kinase (ERK), or of enzymes such as manganese superoxide dismutase (MnSOD) that promote cell survival through protection against oxidative stress and apoptosis. These intriguing findings should stimulate additional research aimed at dissecting the complex cellular mechanisms regulated by AC isoforms and may lead to novel genetic and pharmacological approaches to delay aging-related conditions and to extend life span.

A fair number of bases covered there. "We don't really know yet, but have some places to start looking" would have been fine. Metabolism is complex; there's no end to the resouces we can productively sink into understanding the space of potential beneficial alterations to mammalian metabolic processes. Those same resouces, I feel, would be better directed to understanding how to repair the metabolism we have. After all, if you can repair age-related metabolic damage once, you can come back in ten years time and do it again - and again and again, for so long as you care to continue. If developing that possibility is on the table for the same sort of cost as developing a one-time manipulation that slows the accumulation of damage by 30%, I know which route I'd choose.

This is exactly the choice facing us today, and for some strange reason the mainstream of medical science is headed down the inferior, more costly, less effective path of metabolic manipulation. Comparatively little attention is given to the more effective strategies of repair. Changing this reality is one very good reason to support the work of the Methuselah Foundation.